Deoxycholic Acid Could Induce Apoptosis and Trigger Gastric Carcinogenesis on Gastric Epithelial Cells by Quantitative Proteomic Analysis

Shi, Yanyan; Wei, Ying; Zhang, Ting; Zhang, Jing; Wang, Ye; Ding, Shigang

doi:https://doi.org/10.1155/2016/9638963

Gastroenterology Research and Practice

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2016 | Article ID 9638963 | https://doi.org/10.1155/2016/9638963

Deoxycholic Acid Could Induce Apoptosis and Trigger Gastric Carcinogenesis on Gastric Epithelial Cells by Quantitative Proteomic Analysis

Yanyan Shi,¹Ying Wei,²Ting Zhang,³Jing Zhang,²Ye Wang,²and Shigang Ding²

Academic Editor: Daiming Fan

Received02 Aug 2016

Revised10 Oct 2016

Accepted23 Oct 2016

Published14 Dec 2016

Abstract

Background. Pathologic duodenogastric reflux can induce or aggravate gastritis because of the presence of bile acids. Bile reflux has been generally considered to be associated with intestinal metaplasia and gastric cancer. However, the pathogenic mechanisms of the effects of bile acids on gastric mucosa are still unknown. Methods. To explore the mechanisms by which bile acids induce gastric mucosal lesions, we examined cell apoptosis in the gastric epithelial cell line GES-1 and investigated the changes in protein profiles of GES-1 cells in response to a bile acid deoxycholic acid using a proteomics approach. Changes in the profiles of the differently expressed proteins were analyzed using the DAVID and STRING programs. Results. We found apoptosis was significantly induced in GES-1 cells by deoxycholic acid. Using liquid chromatographic/tandem mass spectrometric (LC-MS/MS) methods, 134 upregulated proteins and 214 downregulated proteins were identified in the bile acid treated GES-1 cells. Bioinformatics analysis revealed the interactions and signaling networks of these differentially expressed proteins. Conclusion. These findings may improve the understanding of the molecular mechanisms underlying the pathogenicity of bile acids on gastric mucosa.

1. Introduction

Reflux of bile is one of the main etiological factors in the pathophysiological processes leading to gastric mucosal lesions in patients with chronic gastritis [1]. Bile reflux gastritis (BRG) has been recognized to be a chemical gastropathy due to excessive duodenogastric reflux. Physiological duodenogastric refluxate does not contain bile acids but only contains and IgA, which might have protective functions for gastric mucosa [2]. Nevertheless, pathologic duodenogastric reflux can be induced by many factors, such as abnormalities in pyloric anatomic structure and antropyloric and duodenal dysmotility, with continuous bile acids secretion. Pathologic duodenogastric reflux can induce or aggravate gastritis because of the presence of bile acids, and high concentration of bile acids may play a critical role in the induction of intestinal metaplasia (IM) in the stomach. Furthermore, bile reflux is also believed to function as an initiator of gastric carcinogenesis [3].

Some studies have found that bile acids and other contents of the duodenum act synergistically in the development of chronic gastritis with gastric acid and Helicobacter pylori infection [4, 5]. Apoptosis and redox reactions have been reported to be associated with bile acid-induced gastritis [6, 7]. Gastric IM induced by bile reflux is considered to be a precancerous gastric adenocarcinomal lesion and is associated with the induction of cyclooxygenase-2 (COX-2). However, the exact pathogenic mechanisms by which bile acids affect the gastric mucosa are still not clear.

In this study, we assessed the influence of a bile acid deoxycholic acid on the gastric epithelial cell line GES-1, and proteomics analysis was used to identify the biological processes and molecular pathways through which deoxycholic acid exerts its pathogenic effects on gastric mucosa.

2. Materials and Methods

2.1. Cells, Culture Conditions, and Deoxycholic Acid Treatment

GES-1 cells and AGS cells were both cultured in RPMI1640 growth medium supplemented with 10% (v/v) fetal bovine serum (Hyclone, Logan, UT, USA) at 37°C in a humidified incubator in 5% (v/v) CO₂. A 10 mM deoxycholic acid (Sigma, St. Louis, MO, USA) stock solution was prepared in PBS and was incubated in a water bath at 37°C for 30 min before each use.

Cells were seeded in growth medium one day before deoxycholic acid treatment. For coculturing of cells and deoxycholic acid, cells were rinsed once with PBS before fresh growth medium was added. Concentrations of 200 μM and 400 μM of deoxycholic acid were used in the preliminary experiment (shown in supplementary figure in Supplementary Material available online at http://dx.doi.org/10.1155/2016/9638963), and 400 μM was chosen in the following studies. Deoxycholic acid was added to the cell medium at the final concentration of 400 μM, and the cells were maintained under normal growth conditions for 10 h. Untreated GES-1 cells were used as controls.

2.2. Apoptosis Assay

GES-1 cells and AGS cells were both seeded in 6-well plates (at a density of 1.2 × 10⁵ cells). After incubating the cells with or without deoxycholic acid for 10 h, an Annexin V-FITC/PI double-staining Apoptosis Detection Kit (Becton Dickinson, Franklin Lakes, NJ, USA) was used to label the cells according to the manufacturer’s instructions. Untreated GES-1 cells were used as negative controls. Cells were washed with cold PBS, and 200 μL of the Annexin V-Binding Buffer was added. After the cells were stained with 10 μL of FITC-labeled Annexin V and 5 μL of PI, they were immediately analyzed by flow cytometry.

2.3. Protein Extraction and SDS-PAGE

GES-1 cells cultured with or without deoxycholic acid were harvested. For protein extraction, cells were suspended in cell lysis buffer containing a protease inhibitor mixture and shaken on ice for 30 min. The cell lysate was centrifuged at 15,000 ×g at 4°C for 10 min, and the supernatant was collected. The total protein concentration was measured by the Bradford method using a BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). Proteins (200 μg) were separated by 15% (w/v) SDS-PAGE. The gels were then stained with Coomassie brilliant blue G-250 (Bio-Rad Laboratories, Hercules, CA, USA) to examine differences between the total proteins of GES-1 cells with and without deoxycholic acid.

2.4. NanoLC-MS/MS and Data Analysis

In this study, a highly specific and sensitive liquid chromatographic/tandem mass spectrometric (LC-MS/MS) method was used to identify differently expressed proteins in GES-1 cells cultured with or without bile acids. The gels were divided into 15 equal pieces according to the proteins’ molecular weights. Proteins were then digested with trypsin and the peptides applied to an EASY-nLC system (Proxeon Biosystem, Thermo Fisher Scientific) coupled online to an ESI-LTQ-OrbitrapVelos mass spectrometer (Thermo Fisher Scientific) mostly as described previously [8]. Peptides were eluted through a trap column and an analytical column packed with C-18 ReproSil 3 μm resin using a gradient from 100% phase A (0.1% formic acid in water) to 35% phase B (0.1% formic acid in acetonitrile) for 150 min. Mass spectra were acquired in a positive mode using the data-dependent automatic (DDA) survey MS scan and tandem mass spectra (MS/MS) acquisition. The DDA survey scan was of the m/z range 350–2000 and resolution 60,000 with a target value of 1 × 10⁻⁶ ions. The survey scan was followed by MS/MS of the 15 most intense ions in the LTQ using the collision-induced dissociation (CID), and previously fragmented ions were dynamically excluded for 30 s. Raw data were searched against the Swiss-Prot human proteome database using MaxQuant software (version 1.2.2.5). Searches were performed with the following parameters: tryptic hydrolysis, two missed cleavages, oxidation of methionine as variable modification, carbamidomethylation as fixed modification, and peptide tolerance of 10 ppm. Search results were subsequently processed/filtered through the Search Engine Processor tool [9] using a 1% false discovery rate (FDR).

Identified proteins were BLAST searched against the NCBI nonredundant database. Ontological analysis of the differentially expressed proteins was performed using the search tool DAVID (http://david.abcc.ncifcrf.gov/). STRING (http://string.embl.de) was used as a database for predicted signaling networks and protein interactions as previously described [10].

2.5. Western Blot Analysis

Protein samples of the two groups were performed by western blotting to validate the differentially expressed proteins. For protein extraction, cells were suspended in cell lysis buffer containing a protease inhibitor mixture and shaken on ice for 30 min. The cell lysate was centrifuged 15,000 ×g at 4°C for 10 min, and the supernatant was collected. The total protein concentration was measured by the Bradford method using a BCA Protein Assay kit. Proteins (70 mg) were separated on 12% (w/v) SDS-PAGE gels and electrophoretically transferred onto PVDF membranes. The membranes were blocked in 5% (w/v) fat-free milk in Tris-buffered saline, 0.5% (v/v) Tween-20, at room temperature for 1 h and incubated overnight at 4°C with antibodies against SOS1 (Flarebio, China; 1 : 500), PTK2 (Flarebio; 1 : 500), ATP12P (Flarebio; 1 : 500), H2AFY (Flarebio; 1 : 500), and α-tubulin (MBL, Japan; 1 : 2000). After three washes in PBS supplemented with 0.1% (v/v) Tween-20 for 15 min, the membranes were incubated with a secondary antibody, goat anti-Rabbit IRDye 680 or goat anti-Mouse IRDye 800CW (LICOR; 1 : 5000), for 1 h at room temperature. Proteins were identified by scanning the membranes using the Odyssey Imager (LI-COR Biosciences).

2.6. Statistical Analysis

The differences between two groups were analyzed using Student’s t-test. Data are presented as the mean ± SD of three independent experiments. All statistical analyses were performed using SPSS 21.0 software. values < 0.05 were considered statistically significant.

3. Results

3.1. Deoxycholic Acid Induced Apoptosis in GES-1 Cells

An apoptosis detection kit was used to detect apoptosis induced by a 400 μM final concentration of deoxycholic acid in GES-1 cells. The results (Figure 1(a)) indicated that deoxycholic acid induced apoptosis in GES-1 cells (). AGS cells were measured in the same way as GES-1 cells (Figure 1(b)).

(a)

(b)

Figure 1

(a) A representative experiment of Annexin V-FITC/PI double-staining of GES-1 cells at 10 h of treatment is shown. The proportion of Annexin V positive cells (AV+: apoptotic cells) in the control and treated groups were, respectively, 10.25% and 73.11%. (b) A representative experiment of Annexin V-FITC/PI double-staining of AGS cells at 10 h of treatment is shown. The proportion of Annexin V positive cells in the control and treated groups were, respectively, 4.54% and 34.9%. Data are presented as the mean ± SD of three independent experiments. compared with the control, values < 0.05 were considered statistically significant.

3.2. Protein Purification and Identification

The proteome of the GES-1 cells was profiled using SDS-PAGE with Coomassie brilliant blue staining and LC-MS/MS. If the ratio of a protein was >2.0 or <0.5 in the cells treated with bile acid relative to negative control cells, the protein was considered to be differentially expressed. In total, 348 differentially expressed proteins were identified, including 214 downregulated proteins and 134 upregulated proteins (shown in supplementary data). The ratios of 14 different proteins were >5.0 or <0.2, including 6 downregulated proteins (Table 1) and 8 upregulated proteins (Table 2), indicating that they are highly regulated and of particular interest.

3.3. Cluster Analysis of the Bile Acid-Regulated Proteins

A heatmap was constructed from the data obtained for the 348 differentially expressed proteins. The clustering analysis of the differentially expressed proteins in the bile acid-treated cells provides evidence that the genes encoding these proteins are regulated by deoxycholic acid (Figure 2).

3.4. Functional Classification and Enrichment of the Bile Acid-Regulated Proteins

The identified differentially expressed proteins were classified into the functional categories shown in Figure 3, and proteins involved in phosphorylation and acetylation were the highest proportions. More interestingly, it is shown that mitochondrial proteins account for approximately 6 percent of the identified proteins, which may play roles in cell apoptosis. To further elucidate the biological processes affected by bile acid, these dysregulated proteins were annotated to the DAVID database for enrichment analysis in terms of biological process, cellular component, and molecular function (Figure 4).

3.5. Analysis of the Signaling Network

The differentially expressed proteins after bile acid treatment were then searched against the STRING database, and 341 proteins had matches in the database. The chosen confidence level (STRING score) was 0.4. A merged network is shown in Figure 5. The substantial significant functions of the proteins in the network were RNA binding, structural constituent of ribosome, nucleic acid binding, and protein kinase regulator activity. ACIN1, AKAP17A, Clorf52, and CID are important proteins in RNA binding and nucleic acid binding. MRPL10, MRPL16, and MRPL17 are important proteins in structural constituent of ribosome. ANKRD54, CALM2, and CDKN2A are important proteins in protein kinase regulator activity. The program predicted associations for a particular group of proteins.

3.6. Verification of Four Identified Proteins

In support of the above results, western blot analysis was conducted to monitor changes in the level of four identified proteins implicated in DNA repair and cell cycle (Figure 6). In comparison with the negative control, core histone macro-H2A.1 (H2AFY) was downregulated after being treated by deoxycholic acid. Son of sevenless homolog 1 (SOS1), focal adhesion kinase 1 (PTK2), and ATP synthase mitochondrial F1 complex assembly factor 2 (ATP12P) were upregulated. These were consistent with the results of quantitative proteomic analysis.

4. Discussion

There is a strong association between the concentration of bile acid in the duodenogastric refluxate and the degree of gastroesophageal reflux disease (GERD), and bile reflux is a main risk factor for Barrett’s esophagus [11, 12]. Bile acid exposure can exacerbate gastric mucosal lesions such as those caused by active or chronic inflammation. Moreover, length of time of bile acid exposure correlates with the severity of pathological changes in the gastric mucosa [1]. In addition, bile acid directly induces intestinal metaplasia and progression to neoplasia of the esophagus and stomach [5, 13, 14].

Although bile acid is thought to be critical in the pathogenesis of gastric mucosal diseases, the mechanisms by which bile acids induce transformation in the stomach are still not clear [15]. Compared with studies of the stomach mucosa, there have been many more studies focusing on mechanisms of esophageal mucosal diseases induced by bile acid. Recent studies indicate that immune responses and/or signaling pathways that regulate cell proliferation or cell phenotypes can cause damage or metaplasia of esophageal epithelial cells [16]. In ex vivo/in vitro studies, bile acids stimulate esophageal cells to produce inflammatory mediators (e.g., IL-8 and COX-2) and cause oxidative stress, DNA damage, and apoptosis. Bile acids also induce squamous cells to change their gene expression pattern to resemble intestinal-type cells and cause Barrett’s cells to increase expression of intestinal-type genes [17]. However, in the gastric mucosa, there are glandular epithelial cells, which are different from squamous cells in esophageal mucosa.

Whether pathogenesis mechanisms of bile acids in the stomach are the same as in esophagus has not been confirmed. The mechanisms of gastric cellular death induced by bile acids remain controversial. In this study, we used proteomics analysis of a human gastric mucosal cell line treated with a bile acid deoxycholic acid to investigate the mechanisms. It has been reported that deoxycholic acid amounted to about 27% of total bile acids. The presence of mainly free secondary and primary bile acids may contribute to the high incidence of cancer in the gastric remnant observed after Billroth operations and reflux of bile exists [18]. Unconjugated bile acids deoxycholic acid and chenodeoxycholic acid could dramatically affect esophageal cells during the development of Barrett’s esophagus, especially deoxycholic acid [19]. Some researchers used deoxycholic acid to establish chronic gastritis animal models [20]. These may indicate deoxycholic acid is one of the most cytotoxic bile acids and has been used previously to study bile or bile acids. Based on this consideration, we used deoxycholic acid in this study. Previous studies reported minimal cellular injury in response to 100 μM or 200 μM deoxycholic acid exposure [21, 22], and higher concentrations of deoxycholic acid (500 μM–1 mM) have been used to study injury to gastric cells and hepatocytes [23]. Moreover, the deoxycholic acid concentration in human gastric remnants after distal gastric resections is approximately 370 μM. Hence, we employed concentrations of 200 μM and 400 μM for 5 h, 10 h, and 24 h in the preliminary experiments (shown in Supplementary Figure S) and chose 400 μM for 10 h finally. Our results showed that deoxycholic acid could induce apoptosis in gastric mucosa cell lines GES-1 and AGS, and the latter cell line AGS was used to avoid the cell-specific effects. Some studies have implicated a necrotic pathway in the effects of deoxycholic acid on gastric cells [22, 24, 25], whereas others have proposed that the effects are due to apoptosis [6, 26]. The present study indicated that apoptosis might be a major mechanism of deoxycholic acid-induced gastric mucosal cell death.

However, the mechanisms for the inflammation- and cancer-induction effects of bile acids on the gastric mucosa have not yet been determined. Proteomics analysis in this study revealed a total of 348 differently expressed proteins, which were found to be involved in diverse biological processes, including RNA binding, structural constituent of the ribosome, nucleic acid binding, and protein kinase regulator activity. Some of the identified proteins have been reported to be involved in inflammation and neoplasia. Core histone macro-H2A.1 and E3 ubiquitin-protein ligase UHRF1 were downregulated, which has been reported to be related with the obstruction of DNA repair and nucleotide metabolism and thus induction of genetic mutations or epigenetic defects [27, 28]. Proteins involved in cell proliferation, including the membrane associated proteins n-chimaerin [29], son of sevenless homolog 1 [30, 31], and focal adhesion kinase 1 [32] were upregulated. In contrast, Bcl2, an antagonist of cell death, was downregulated. Our observations suggested that cell proliferation was triggered after bile acid treatment. The cells might undergo genomic events leading to foveolar hyperplasia, which is one of the important histopathological features of reflux gastritis and is essential for tumorigenesis [33]. ATP synthase mitochondrial F1 complex assembly factor 2 was also upregulated, suggesting enhanced oxidative phosphorylation and accelerated energy metabolism [34, 35], which is consistent with an increase in cell proliferation. Besides, some studies have reported that when cell proliferation is stimulated, cell apoptosis is meanwhile easier to be induced. Oncogene activation could meanwhile make cells more sensitive to apoptosis. The procedures of cell proliferation and apoptosis are coupled with each other [36–38]. Bile reflux is believed to function as an initiator of gastric carcinogenesis [39, 40]. Our results imply that bile acids would drive the development and progression of bile reflux gastritis and even gastric cancer.

Collectively, our results suggest that bile reflux is one of the primary factors in the pathogenesis of gastric mucosal lesions and should be the focus of further attention. Apoptosis of gastric mucosal cells could be induced by deoxycholic acid. Proteomics analysis identified the differently expressed proteins in GES-1 cells treated with deoxycholic acid. These findings improve our understanding of the molecular mechanisms underlying the effects of deoxycholic acid on gastric mucosa cells. Future researches should be performed in patients to further investigate the clinical relations of the proteins identified from this vitro study.

5. Conclusions

In summary, our integrated analysis revealed a profile of differently expressed proteins in deoxycholic acid-treated gastric mucosal cells. Moreover, the results of function enrichment analysis revealed that some of these proteins may have biological functions related to the development of gastric mucosal diseases induced by deoxycholic acid, including in RNA splicing, macromolecular complex subunit organization, and nucleosome organization. The signaling network analysis may contribute to further understanding the underlying regulatory mechanisms of bile acid-induced gastric lesions, including gastric cancer.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This study was funded by Key laboratory for Helicobacter pylori infection and Upper Gastrointestinal Diseases, Beijing Key Laboratory (no. BZ0371), and Chinese National Natural Science Foundation of China (Grant no. 81270475).

Supplementary Materials

GES-1 cells were exposed to deoxycholate acid (200 μM and 400 μM) for 5 h, 10 h, 24 h. Results are presented as mean ± s.d. of three independent experiments. Cell apoptosis is concentration- and time- dependent after treated with deoxycholate acid.

Supplementary Material

References

S.-L. Chen, J.-Z. Mo, Z.-J. Cao, X.-Y. Chen, and S.-D. Xiao, “Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis,” World Journal of Gastroenterology, vol. 11, no. 18, pp. 2834–2837, 2005.
View at: Publisher Site | Google Scholar
J. Dalenbäck, H. Abrahamson, B. Björnson et al., “Human duodenogastric reflux, retroperistalsis, and MMC,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 275, no. 3, pp. R762–R769, 1998.
View at: Google Scholar
M. J. Park, K. H. Kim, H. Y. Kim, K. Kim, and J. Cheong, “Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells,” Carcinogenesis, vol. 29, no. 12, pp. 2385–2393, 2008.
View at: Publisher Site | Google Scholar
A. Zullo, V. Rinaldi, C. Hassan, V. Lauria, and A. F. Attili, “Gastric pathology in cholecystectomy patients: role of Helicobacter pylori and bile reflux,” Journal of Clinical Gastroenterology, vol. 27, no. 4, pp. 335–338, 1998.
View at: Publisher Site | Google Scholar
T. Matsuhisa and T. Tsukui, “Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens,” Journal of Clinical Biochemistry and Nutrition, vol. 50, no. 3, pp. 217–221, 2012.
View at: Publisher Site | Google Scholar
M. J. Redlak, M. S. Dennis, and T. A. Miller, “Apoptosis is a major mechanism of deoxycholate-induced gastric mucosal cell death,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 285, no. 5, pp. G870–G879, 2003.
View at: Publisher Site | Google Scholar
Y. Xu, T. Watanabe, T. Tanigawa et al., “Bile acids induce Cdx2 expression through the farnesoid X receptor in gastric epithelial cells,” Journal of Clinical Biochemistry and Nutrition, vol. 46, no. 1, pp. 81–86, 2010.
View at: Publisher Site | Google Scholar
C. B. Pinheiro, M. Shah, E. L. Soares et al., “Proteome analysis of plastids from developing seeds of Jatropha curcas L.,” Journal of Proteome Research, vol. 12, no. 11, pp. 5137–5145, 2013.
View at: Publisher Site | Google Scholar
P. C. Carvalho, J. S. G. Fischer, T. Xu et al., “Search engine processor: filtering and organizing peptide spectrum matches,” Proteomics, vol. 12, no. 7, pp. 944–949, 2012.
View at: Publisher Site | Google Scholar
W. Deng, M. Yan, T. Yu et al., “Quantitative proteomic analysis of the metastasis-inhibitory mechanism of miR-193a-3p in non-small cell lung cancer,” Cellular Physiology and Biochemistry, vol. 35, no. 5, pp. 1677–1688, 2015.
View at: Publisher Site | Google Scholar
M. F. Vaezi and J. E. Richter, “Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease,” Gastroenterology, vol. 111, no. 5, pp. 1192–1199, 1996.
View at: Publisher Site | Google Scholar
D. Nehra, P. Howell, C. P. Williams, J. K. Pye, and J. Beynon, “Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity,” Gut, vol. 44, no. 5, pp. 598–602, 1999.
View at: Publisher Site | Google Scholar
P. M. Newberne, G. Charnley, K. Adams et al., “Gastric and oesophageal carcinogenesis: models for the identification of risk and protective factors,” Food and Chemical Toxicology, vol. 24, no. 10, pp. 1111–1119, 1986.
View at: Publisher Site | Google Scholar
T. Matsuhisa, T. Arakawa, T. Watanabe et al., “Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases,” Digestive Endoscopy, vol. 25, no. 5, pp. 519–525, 2013.
View at: Publisher Site | Google Scholar
Y. Yuasa, “Control of gut differentiation and intestinal-type gastric carcinogenesis,” Nature Reviews Cancer, vol. 3, no. 8, pp. 592–600, 2003.
View at: Publisher Site | Google Scholar
R. F. Souza, “The role of acid and bile reflux in oesophagitis and Barrett's metaplasia,” Biochemical Society Transactions, vol. 38, no. 2, pp. 348–352, 2010.
View at: Publisher Site | Google Scholar
K. R. McQuaid, L. Laine, M. B. Fennerty, R. Souza, and S. J. Spechler, “Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia,” Alimentary Pharmacology & Therapeutics, vol. 34, no. 2, pp. 146–165, 2011.
View at: Publisher Site | Google Scholar
L. Domellof, B. S. Reddy, and J. H. Weisburger, “Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy,” American Journal of Surgery, vol. 140, no. 2, pp. 291–295, 1980.
View at: Publisher Site | Google Scholar
Y. Hu, V. A. Williams, O. Gellersen, C. Jones, T. J. Watson, and J. H. Peters, “The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells,” Journal of Gastrointestinal Surgery, vol. 11, no. 7, pp. 827–834, 2007.
View at: Publisher Site | Google Scholar
Z. Xiang, J.-M. Si, and H.-D. Huang, “Chronic gastritis rat model and role of inducing factors,” World Journal of Gastroenterology, vol. 10, no. 21, pp. 3212–3214, 2004.
View at: Publisher Site | Google Scholar
A. J. Dziki, S. Batzri, J. W. Harmon, and M. Molloy, “Cellular hypercalcemia is an early event in deoxycholate injury of rabbit gastric mucosal cells,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 269, no. 2, part 1, pp. G287–G296, 1995.
View at: Google Scholar
E. R. Kokoska, G. S. Smith, A. B. Wolff et al., “Role of calcium in adaptive cytoprotection and cell injury induced by deoxycholate in human gastric cells,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 275, no. 2, pp. G322–G330, 1998.
View at: Google Scholar
K. Okano, K. J. Ivey, T. Sugimoto et al., “Stimulation of prostaglandin E₂ release from cultured rabbit gastric cells by sodium deoxycholate,” Prostaglandins, vol. 47, no. 6, pp. 423–436, 1994.
View at: Publisher Site | Google Scholar
A. J. Dziki, S. Batzri, J. W. Harmon, and M. Molloy, “Cellular hypercalcemia is an early event in deoxycholate injury of rabbit gastric mucosal cells,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 269, no. 2, pp. G287–G296, 1995.
View at: Google Scholar
E. R. Kokoska, G. S. Smith, C. L. Rieckenberg, Y. Deshpande, A. Banan, and T. A. Miller, “Adaptive cytoprotection against deoxycholate-induced injury in human gastric cells in vitro: is there a role for endogenous prostaglandins?” Digestive Diseases and Sciences, vol. 43, no. 4, pp. 806–815, 1998.
View at: Publisher Site | Google Scholar
C.-H. Cho and J.-Y. Wang, Gastrointestinal Mucosal Repair and Experimental Therapeutics, vol. 25, Karger Medical and Scientific Publishers, 2002.
W. Qin, H. Leonhardt, and F. Spada, “Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1,” Journal of Cellular Biochemistry, vol. 112, no. 2, pp. 439–444, 2011.
View at: Publisher Site | Google Scholar
S. Magdeldin, T. Yamamoto, I. Tooyama, and E. M. Abdelalim, “New proteomic insights on the role of NPR-A in regulating self-renewal of embryonic stem cells,” Stem Cell Reviews and Reports, vol. 10, no. 4, pp. 561–572, 2014.
View at: Google Scholar
N. Miyake, J. Chilton, M. Psatha et al., “Human CHN1 mutations hyperactivate α2-chimaerin and cause Duane's retraction syndrome,” Science, vol. 321, no. 5890, pp. 839–843, 2008.
View at: Publisher Site | Google Scholar
H.-H. Jeng, L. J. Taylor, and D. Bar-Sagi, “Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis,” Nature Communications, vol. 3, article 1168, 2012.
View at: Publisher Site | Google Scholar
M. Poltorak, I. Meinert, J. C. Stone, B. Schraven, and L. Simeoni, “Sos1 regulates sustained TCR-mediated Erk activation,” European Journal of Immunology, vol. 44, no. 5, pp. 1535–1540, 2014.
View at: Publisher Site | Google Scholar
U. Pongchairerk, J.-L. Guan, and V. Leardkamolkarn, “Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1,” World Journal of Gastroenterology, vol. 11, no. 37, pp. 5845–5852, 2005.
View at: Publisher Site | Google Scholar
M. F. Dixon, H. J. O'Connor, A. T. R. Axon, R. F. King, and D. Johnston, “Reflux gastritis: distinct histopathological entity?” Journal of Clinical Pathology, vol. 39, no. 5, pp. 524–530, 1986.
View at: Publisher Site | Google Scholar
A. Power, N. Pearson, T. Pham, C. Cheung, A. Phillips, and A. Hickey, “Uncoupling of oxidative phosphorylation and ATP synthase reversal within the hyperthermic heart,” Physiological Reports, vol. 2, no. 9, pp. e12138–e12138, 2014.
View at: Publisher Site | Google Scholar
C.-H. Su, G. P. McStay, and A. Tzagoloff, “Assembly of the rotor component of yeast mitochondrial ATP synthase is enhanced when Atp9p is supplied by Atp9p-Cox6p complexes,” Journal of Biological Chemistry, vol. 289, no. 45, pp. 31605–31616, 2014.
View at: Publisher Site | Google Scholar
J. Flint and T. Shenk, “Viral transactivating proteins,” Annual Review of Genetics, vol. 31, pp. 177–212, 1997.
View at: Publisher Site | Google Scholar
N. D. Perkins, L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel, “Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator,” Science, vol. 275, no. 5299, pp. 523–527, 1997.
View at: Publisher Site | Google Scholar
W. W. Marhin, S. Chen, L. M. Facchini, A. J. Fornace Jr., and L. Z. Penn, “Myc represses the growth arrest gene gadd45,” Oncogene, vol. 14, no. 23, pp. 2825–2834, 1997.
View at: Publisher Site | Google Scholar
M. Tatsugami, M. Ito, S. Tanaka et al., “Bile acid promotes intestinal metaplasia and gastric carcinogenesis,” Cancer Epidemiology Biomarkers and Prevention, vol. 21, no. 11, pp. 2101–2107, 2012.
View at: Publisher Site | Google Scholar
W. Cao, W. Tian, J. Hong et al., “Expression of bile acid receptor TGR5 in gastric adenocarcinoma,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 304, no. 4, pp. G322–G327, 2013.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 Yanyan Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1394

Downloads

1301

Citations